MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 40 filers reported holding MYMD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $863,311 | -60.5% | 1,458,295 | 0.0% | 0.00% | – |
| Q2 2023 | $2,187,443 | -12.8% | 1,458,295 | 0.0% | 0.00% | – |
| Q1 2023 | $2,508,267 | +49.6% | 1,458,295 | 0.0% | 0.00% | – |
| Q4 2022 | $1,677,039 | -55.9% | 1,458,295 | +0.0% | 0.00% | – |
| Q3 2022 | $3,804,000 | +20.3% | 1,457,655 | 0.0% | 0.00% | – |
| Q2 2022 | $3,163,000 | -53.4% | 1,457,655 | 0.0% | 0.00% | – |
| Q1 2022 | $6,792,000 | -23.5% | 1,457,655 | -0.5% | 0.00% | – |
| Q4 2021 | $8,877,000 | -19.1% | 1,464,763 | -3.8% | 0.00% | – |
| Q3 2021 | $10,968,000 | +14.1% | 1,523,304 | -0.1% | 0.00% | – |
| Q2 2021 | $9,609,000 | – | 1,525,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 309,178 | $671,000 | 0.14% |
| Taylor & Morgan Wealth Management, LLC | 17,086 | $37,000 | 0.04% |
| Ikarian Capital, LLC | 81,089 | $176,000 | 0.03% |
| Corundum Group, Inc. | 19,600 | $43,000 | 0.03% |
| M Holdings Securities, Inc. | 70,909 | $154,000 | 0.02% |
| Praetorian Wealth Management, Inc. | 15,000 | $32,000 | 0.01% |
| Western Wealth Management, LLC | 27,050 | $115,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 1,073,765 | $2,330,000 | 0.01% |
| Virtu Financial LLC | 16,063 | $35,000 | 0.00% |
| SeaCrest Wealth Management, LLC | 6,800 | $15,000 | 0.00% |